AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 140.7 SEK -0.21% Market Closed
Market Cap: 17.1B SEK
Have any thoughts about
AddLife AB?
Write Note

Intrinsic Value

The intrinsic value of one ALIF B stock under the Base Case scenario is 163.82 SEK. Compared to the current market price of 140.7 SEK, AddLife AB is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALIF B Intrinsic Value
163.82 SEK
Undervaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AddLife AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALIF B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALIF B?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about AddLife AB

Provide an overview of the primary business activities
of AddLife AB.

What unique competitive advantages
does AddLife AB hold over its rivals?

What risks and challenges
does AddLife AB face in the near future?

Has there been any significant insider trading activity
in AddLife AB recently?

Summarize the latest earnings call
of AddLife AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AddLife AB.

Provide P/S
for AddLife AB.

Provide P/E
for AddLife AB.

Provide P/OCF
for AddLife AB.

Provide P/FCFE
for AddLife AB.

Provide P/B
for AddLife AB.

Provide EV/S
for AddLife AB.

Provide EV/GP
for AddLife AB.

Provide EV/EBITDA
for AddLife AB.

Provide EV/EBIT
for AddLife AB.

Provide EV/OCF
for AddLife AB.

Provide EV/FCFF
for AddLife AB.

Provide EV/IC
for AddLife AB.

Show me price targets
for AddLife AB made by professional analysts.

What are the Revenue projections
for AddLife AB?

How accurate were the past Revenue estimates
for AddLife AB?

What are the Net Income projections
for AddLife AB?

How accurate were the past Net Income estimates
for AddLife AB?

What are the EPS projections
for AddLife AB?

How accurate were the past EPS estimates
for AddLife AB?

What are the EBIT projections
for AddLife AB?

How accurate were the past EBIT estimates
for AddLife AB?

Compare the revenue forecasts
for AddLife AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AddLife AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AddLife AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of AddLife AB compared to its peers.

Compare the P/E ratios
of AddLife AB against its peers.

Discuss the investment returns and shareholder value creation
comparing AddLife AB with its peers.

Analyze the financial leverage
of AddLife AB compared to its main competitors.

Show all profitability ratios
for AddLife AB.

Provide ROE
for AddLife AB.

Provide ROA
for AddLife AB.

Provide ROIC
for AddLife AB.

Provide ROCE
for AddLife AB.

Provide Gross Margin
for AddLife AB.

Provide Operating Margin
for AddLife AB.

Provide Net Margin
for AddLife AB.

Provide FCF Margin
for AddLife AB.

Show all solvency ratios
for AddLife AB.

Provide D/E Ratio
for AddLife AB.

Provide D/A Ratio
for AddLife AB.

Provide Interest Coverage Ratio
for AddLife AB.

Provide Altman Z-Score Ratio
for AddLife AB.

Provide Quick Ratio
for AddLife AB.

Provide Current Ratio
for AddLife AB.

Provide Cash Ratio
for AddLife AB.

What is the historical Revenue growth
over the last 5 years for AddLife AB?

What is the historical Net Income growth
over the last 5 years for AddLife AB?

What is the current Free Cash Flow
of AddLife AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for AddLife AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AddLife AB

Current Assets 3.8B
Cash & Short-Term Investments 264m
Receivables 1.8B
Other Current Assets 1.8B
Non-Current Assets 9.1B
Long-Term Investments 129m
PP&E 1.1B
Intangibles 7.9B
Current Liabilities 3.2B
Other Current Liabilities 3.2B
Non-Current Liabilities 4.6B
Long-Term Debt 4B
Other Non-Current Liabilities 556m
Efficiency

Earnings Waterfall
AddLife AB

Revenue
10B SEK
Cost of Revenue
-6.3B SEK
Gross Profit
3.7B SEK
Operating Expenses
-3.2B SEK
Operating Income
500m SEK
Other Expenses
-383m SEK
Net Income
117m SEK

Free Cash Flow Analysis
AddLife AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALIF B Profitability Score
Profitability Due Diligence

AddLife AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
49/100
Profitability
Score

AddLife AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ALIF B Solvency Score
Solvency Due Diligence

AddLife AB's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
48/100
Solvency
Score

AddLife AB's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALIF B Price Targets Summary
AddLife AB

There are no price targets for ALIF B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALIF B?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ALIF B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALIF B Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

AddLife AB Logo
AddLife AB

Country

Sweden

Industry

Life Sciences Tools & Services

Market Cap

17.1B SEK

Dividend Yield

0.36%

Description

AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Contact

STOCKHOLM
Stockholm
Brunkebergstorg 5, Box 3145
+46842003830.0
www.add.life

IPO

2015-03-16

Employees

1 778

Officers

President & CEO
Mr. Fredrik Dalborg
Chief Financial Officer
Ms. Christina Rubenhag
Investor Relations Manager
Julie O'Leary
Head of Business Development
Christian Karlsson
Head of Organic Growth & Profitability
Per Wahlstedt
Head of Sustainability
Timmy Rosendal
Show More
Head of Business Unit BioMedical & Research
Mr. Mattias Bengtsson
Head of Business Unit Hospital
Mr. Luca Marenzi M.B.A.
Head of Business Unit Diagnostics
Kai Rantanen
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALIF B stock?

The intrinsic value of one ALIF B stock under the Base Case scenario is 163.82 SEK.

Is ALIF B stock undervalued or overvalued?

Compared to the current market price of 140.7 SEK, AddLife AB is Undervalued by 14%.

Back to Top